Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I FLOT as First-line Treatment in Metastatic Gastric Cancer (Japan)
jRCTs041200044Phase 1Completed
- Start
- Oct 2020
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of docetaxel, oxaliplatin, fluorouracil and levoleucovorin in gastric cancer (GC) (2 cohorts). Primary endpoints: Dose-limiting toxicity (DLT) - General cohort (Part 1) and Dose-limiting toxicity (DLT) - SPM cohort (Part 2). Started Oct 2020; status: completed.
02
Drugs
docetaxeloxaliplatinfluorouracillevoleucovorin
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on jRCTs041200044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041200044.